Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thanks guys
So you’re telling me a publicly traded company is giving away “gifts or deals” for somebody that bought their shares back when they were .07 cents 3 years ago? They’ve also listed him as a director in this official SEDI filing, but this is false information in order to provide a “gift”? Sounds fishy to me. I supported the company at .07 cents to... I’m still waiting for my gift! Thanks Flair... but something seems “off” here. I’ll make some calls this week, as I’m now very curious.
I’m curious about who this Director is that is holding a ton of cheap shares... and why he hasn’t been announced as of yet.
SEDI report
Paul Chow
2 trans 2018-09-12
420,000 common shares @ .06
420,000 warrants @ .10
His total common shares now equals 3,642,937
A tad bit of a large holding now, not too mention a hell of a deal Inmed has gifted him! Hope he is somebody significant.
Maybe just grasping on hope... but GW just closed a quick oversubscribed financing of 346 million. Wouldn’t it be nice if Inmed was doing a licence with them for CBD production? According to Josh Blacher in last interview they’re not not really interested in CBD & THC production and just focusing on minor cannibinoids... why not get a little kickback for building their facility and let GW go wild for their own needs?
Expect the CMO announcement in the near future. Inmed is planning on going in prepared.
Why not make use of this facility to get all your ducks in row first? Makes more sense than hitting the CMO with “all guns a blazin” and fumbling around the process until it’s done. This is where Patterson will be grooming our team.
I hope you’re kidding! If not you’d better change your brand of smoke Dragon.
This is great news and a big step going forward for Biosynthesis. NRC has a training facility for scale-up complete with scientists and engineers. This is the place where they polish the process :)
Don’t be such a grump ;) I just ran into the page and thought I’d share. I’m getting a little impatient with waiting too.
If anyone cares... the job listing on Inmed career site for scientist was pulled from the site which hopefully means its been filled.
October 17 Eric Adams will be in San Fran pumping Inmed at the Bio Investor Forum striking when the pipe is smokin hot!
http://bioinvestorforum18.azurewebsites.net/SessionDetail.aspx?id=495127
Not in the “Wild World Of Trump”!
I got this from the GW board, not sure of the accuracy:
CNBC has the news that CBD will be rescheduled to IV, same as ambient, xanax, and tramadol. Very good news - they could have just moved it down one level. This opens up a big market, covered by insurance.
https://420intel.com/articles/2018/07/04/dea-rescheduling-epidiolex-not-yet-cannabis-or-cbd
This article indicates September 23, I’ve seen this date indicated several times.
We longs just have to wait and see now.
What I expected. Still have to wait on DEA rescheduling and a reminder we’re still not at the end of third quarter.
Didn’t like how the vagueness on CMO decisions are sounding. Like they haven’t even had any real discussions yet. Hope that is wrong.
The person wanting to know about water solubility of cannibinoids : yes they are. Can’t make a “hydrogel” (Glaucoma) if oil soluble, that then requires emulsifying which creates a murky end product, not ideal for use on the eye. So yes, they do have a end product ideal for food and beverage industry. Hope Eric saved the contact numbers after blowing off all the big growers interested in our product!
Wasn’t all that thrilled with what I’ve already read, but wasn’t expecting much either. Hopefully the conference will shed more light.
The new Director Paul Chow has me puzzled. Shares at .06 and warrants at .10 issued. He already owns over 3 million shares and from what I can tell the transaction date listed on Sedi he’s had a file with this company since 2011, which is back when it was Schneiders’ Meridex Software. Or perhaps he was with Biogen and bought into before buyout?
That must be in the same store I saw that Sabre Toothed Tiger print dress I’ve been dreaming about!
So no dead bouncing kitties I hope?
As excited as people are before this conference on Thursday, we won’t be getting anything substantial unless a “halt” the day day or day before trading. Personally, I don’t believe the wait is over and prices will dip before the “real news”.
Next big question is when are we going to the NASDAQ? That will answer everything!
I’m sorry you couldn’t buy any warrants Flair. I’ve watched that little investment more than double today :)
I’m pretty positive we’ll hear about PCT filing on or before the conference date. I doubt we’ll hear anything concrete as far as Biosynthesis future. That will be after DEA rescheduling date. Say they were to go forward with Eli Lily, who has the experience and set-up in the States with E-coli technique. If DEA is positive, then they’ll press-on in the facilities in the States. If not, Inmed will be forced to make their own facility in Canada or EU with their partner (Eli Lily) so they may sell their Cannibinoids to GW or any other parties without legalities. Hopeful speculation of course, but the stock price won’t be doing much for the short-term. Maybe we’ll see a closed deal Oct-Nov.
I’m looking forward to conference call next week. Hopefully some clarity with what they’re moving forward with.
Love the expansion on drug platforms.
Don’t love the no mention of their Chief Scientific Officer Dr. Muhammad.
Knowing how long it takes this company to do website updates... it seems there is still uncertainty with proceeding with Biosynthesis. Not loving that either:(
Certainly hope you’re wrong. Have to admit I’m feeling a little uneasy with latest sell off. But will give benefit to the doubt until end of third quarter.
My hopes are not up, as it is Josh Blacher doing the presentation this week. But this should be a good month for us regardless. Lots coming up!
Based on?... hope?
As hard as it is... sit tight till the end of third quarter. If nothing happens... then the squawking and complaining should commence on this company. But according to their last 2 presentations... we should hear something.
I have to agree with you on all points. The Director does have plenty of more shares, but the fact that he’s selling doesn’t sit well. We wait on the company and what they’ve prioritized being Biosynthesis. This is supposed to be announced this quarter, and if not there will be some challenges going forward keeping investor faith.
If he has kids that only means one thing, Tuition!
My opinion... and only mine, is this is a newly created position. Alexandra Mancini got a huge amount of options last round probably for her work on EB. She’ll take that baby through to the end. Not much time for the other trials so a new person would be imminent if this company has funding for future endeavours.
Another addition to the Careers page of Inmed.
https://www.inmedpharma.com/about-us/careers/
This one looking for a Scientist Pre-clinical for pain and glaucoma pipelines.
Looks like things are getting a little more serious. They’ve been very cautious with taking anything to trials until Biosynthesis was locked in. Maybe this ensures our future funding for days ahead.
A Tommy Chong endorsement won’t do much for the cause. But sure would be nice to see him and Cheech get back together for another movie! Oh the fun they would have NOW! I would even go to a theatre to support it :)
I think we’ll settle in at .90 CDN (the last financing price)... then hopefully up, up and away!
Well I’m certainly hoping there’s no “bouncing dead kitty cats” around here. This looks more like a well needed correction. Hopefully goes to .90 CDN with support until the expected activity in September. But then again... you could be right. I hate these spikes on no news with this company.
You must be offside here. I’m not doing well on most my stocks either, but this is still performing well for us who got in early. Hoping to add more next week.
I don’t have any problem at all with your critiques of the Company, it’s the childish personal attacks we can do without.
Most of us here have been invested at a much lower average than the current price, but yes no updates and constant pushback of trials are testing my patience.
Honestly, don’t take it so personally. You’ve seen the crap that gets through on other boards. This is nothing! Chill and have a cold one! I promise us children will behave (Portfoliomaster exempt)
We might still have a tough ride ahead. News, or even an update on that sorely neglected website would help. A little sorry I didn’t sell any when 2+, especially at these prices. But this is a long term commitment, as hard as it is too stomach some days. Hoping to free up some capital on this downward turn though.
Sure hope this DEA rescheduling happens soon so we can get going. I doubt the PCT filing next month will do much for share price. I’d love to buy more at these prices, but all my stocks are “sucking wind” right now. Probably more hard days ahead too.
Thanks for sharing Flair!
Perhaps he didn’t like his “mention” in that sleazy pump piece by “jimmy what’s-his-name”. Funny how the company never mentioned any association/disassociation about it.
If Dr.Ado Muhammad left the company, isn’t Inmed responsible for making this information available to shareholders? I believe nothing until I see it. Still long.